Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Non-cash Items: 2014-2025

Historic Non-cash Items for Aytu Biopharma (AYTU) over the last 9 years, with Jun 2025 value amounting to $100,000.

  • Aytu Biopharma's Non-cash Items rose 64.76% to $103,898 in Q3 2025 from the same period last year, while for Sep 2025 it was $103,898, marking a year-over-year increase of 64.76%. This contributed to the annual value of $100,000 for FY2025, which is 50.00% down from last year.
  • Aytu Biopharma's Non-cash Items amounted to $100,000 in FY2025, which was down 50.00% from $200,000 recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Non-cash Items ranged from a high of $200,000 in FY2024 and a low of $3,022 during FY2023.
  • For the 3-year period, Aytu Biopharma's Non-cash Items averaged around $101,007, with its median value being $100,000 (2025).
  • Per our database at Business Quant, Aytu Biopharma's Non-cash Items tumbled by 94.47% in 2023 and then surged by 6,518.13% in 2024.
  • Aytu Biopharma's Non-cash Items (Yearly) stood at $54,539 in 2021, then climbed by 0.20% to $54,649 in 2022, then tumbled by 94.47% to $3,022 in 2023, then soared by 6,518.13% to $200,000 in 2024, then slumped by 50.00% to $100,000 in 2025.